FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40474811000001105: Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Feb 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2164781000001113 Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2164791000001110 Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet Has AMP Stalevo 150mg/37.5mg/200mg tablets (Doncaster Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet Is a Generic Stalevo 150mg/37.5mg/200mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet Has specific active ingredient Carbidopa true Inferred relationship Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet Has specific active ingredient Entacapone true Inferred relationship Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start